Yerly S - Search Results

1

Host Genomics of the HIV-1 Reservoir Size and Its Decay Rate During Suppressive Antiretroviral Treatment.

Thorball CW, Borghesi A, Bachmann N, Von Siebenthal C, Vongrad V, Turk T, Neumann K, Beerenwinkel N, Bogojeska J, Roth V, Kok YL, Parbhoo S, Wieser M, Böni J, Perreau M, Klimkait T, Yerly S, Battegay M, Rauch A, Schmid P, Bernasconi E, Cavassini M, Kouyos RD, Günthard HF, Metzner KJ, Fellay J; Swiss HIV Cohort Study. Thorball CW, et al. Among authors: yerly s. J Acquir Immune Defic Syndr. 2020 Dec 1;85(4):517-524. doi: 10.1097/QAI.0000000000002473. J Acquir Immune Defic Syndr. 2020. PMID: 33136754 Free article.

2

Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine.

Yerly S, Kaiser L, Baumberger C, Hirschel B, Perrin LH. Yerly S, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 1;8(4):358-64. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7882100

3

Acute HIV infection.

Perrin L, Yerly S. Perrin L, et al. Among authors: yerly s. J Biol Regul Homeost Agents. 1995 Jul-Sep;9(3):95-9. J Biol Regul Homeost Agents. 1995. PMID: 8782015 Review.

4

Detection of low HIV-1 RNA levels in plasma.

Schockmel GA, Yerly S, Perrin L. Schockmel GA, et al. Among authors: yerly s. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Feb 1;14(2):179-83. doi: 10.1097/00042560-199702010-00013. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9052729

5

A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study.

Rutschmann OT, Opravil M, Iten A, Malinverni R, Vernazza PL, Bucher HC, Bernasconi E, Sudre P, Leduc D, Yerly S, Perrin LH, Hirschel B. Rutschmann OT, et al. Among authors: yerly s. AIDS. 1998 May 28;12(8):F71-7. doi: 10.1097/00002030-199808000-00003. AIDS. 1998. PMID: 9631134 Clinical Trial.

6

Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study.

Lorenzi P, Opravil M, Hirschel B, Chave JP, Furrer HJ, Sax H, Perneger TV, Perrin L, Kaiser L, Yerly S. Lorenzi P, et al. Among authors: yerly s. AIDS. 1999 Feb 4;13(2):F17-21. doi: 10.1097/00002030-199902040-00001. AIDS. 1999. PMID: 10202819

7

Transmission of antiretroviral-drug-resistant HIV-1 variants.

Yerly S, Kaiser L, Race E, Bru JP, Clavel F, Perrin L. Yerly S, et al. Lancet. 1999 Aug 28;354(9180):729-33. doi: 10.1016/S0140-6736(98)12262-6. Lancet. 1999. PMID: 10475184

8

Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort Study.

Yerly S, Kaiser L, Perneger TV, Cone RW, Opravil M, Chave JP, Furrer H, Hirschel B, Perrin L. Yerly S, et al. AIDS. 2000 Feb 18;14(3):243-9. doi: 10.1097/00002030-200002180-00006. AIDS. 2000. PMID: 10716500

9

Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study.

Rutschmann OT, Opravil M, Iten A, Malinverni R, Vernazza PL, Bucher H, Bernasconi E, Perrin LH, Yerly S, Hirschel B. Rutschmann OT, et al. Among authors: yerly s. Antivir Ther. 1998;3 Suppl 4:65-7. Antivir Ther. 1998. PMID: 10723515 Clinical Trial.

10

Acute HIV infection: impact on the spread of HIV and transmission of drug resistance.

Yerly S, Vora S, Rizzardi P, Chave JP, Vernazza PL, Flepp M, Telenti A, Battegay M, Veuthey AL, Bru JP, Rickenbach M, Hirschel B, Perrin L; Swiss HIV Cohort Study. Yerly S, et al. AIDS. 2001 Nov 23;15(17):2287-92. doi: 10.1097/00002030-200111230-00010. AIDS. 2001. PMID: 11698702

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

510 results

Search Page